Abstract. The usefulness of human telomerase reverse transcriptase (hTERT) gene promoter has been proposed in cancer-targeted gene therapy. However, this promoter may not be strong enough to achieve therapeutic levels of transgene expression. In this study, we tested an 'indirected-activator' strategy that utilizes radiation to increase the activity of the hTERT gene promoter. We demonstrated that hTERT may participate in the process of DNA repair induced by irradiation. We found that Zidovudine (AZT, an hTERT inhibitor) can decrease the telomerase activity in human HEp-2 larynx squamous carcinoma cells and lower the survival fraction of HEp-2 cells exposed to radiation. In HEp-2 cells exposed to 6 Gy-radiation, the hTERT promoter showed 2.9-fold higher activity compared with unirradiated cells. Importantly, an increased expression of enzyme horseradish peroxidase (HRP) controlled by the hTERT promoter was found in the transfected cells after irradiation, which coincided with a higher killing rate for HEp-2 cells after prodrug indole-3-acetic acid (IAA; converted by HRP into a cytotoxin) incubation combined with irradiation or not. Our observations suggest that hTERT promoter-mediated gene therapy could be improved in combination with radiotherapy, which may be due to cellular DNA damage responses.
Introduction
Telomeres play an important role in maintaining chromosomal integrity and function. Telomerase, responsible for maintaining telomere function through the addition of telomere repeats to chromosome ends, is a ribonucleoprotein complex and is activated in most cancer cells, but not in most normal cells (1) . Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of telomerase that determines the telomerase activity (2) . Thus, the hTERT gene promoter has been widely used in gene therapy for targeted cancer cells (3) . However, the promoter activity may not be strong enough to induce the expression of a significant amount of a therapeutic gene product required to kill cancer cells (3, 4) .
Radiotherapy is one of the major clinical options for malignant tumors, while cellular DNA damage responses are triggered when cells are exposed to irradiation. Previous studies have reported an initial increase of telomerase activity after irradiation in human colon carcinoma, lymphoma, myeloma cells and Ewing xenograft tumors (5) (6) (7) (8) . We previously observed the up-regulation of telomerase activity in human U251 malignant glioma cells after 2 Gy-radiation exposure, which may be a reaction to DNA damage induced by irradiation. Our data suggested a role of telomerase in the healing of chromosome breaks by radiation-induced DNA damage (9) . The above suggests that precise irradiation may benefit targeted enhancement of hTERT promoter activity, which is promising in targeted cancer gene therapy.
In this study, we examined the usefulness of a strategy, referred to as 'indirected-activator' strategy, in potential radio-gene-therapy. The strategy uses radiation as a first activator to induce DNA damage and in turn, cellular DNA damage responses serve as a second activator to enable an enhancement of hTERT promoter activity. We treated HEp-2 cells with an hTERT inhibitor, Zidovudine (AZT), and then telomerase activity and clonogenic survival fraction were measured after irradiation to understand the mechanism (s) of the increased activity. In addition, we evaluated the radiationinduced activities of hTERT promoter and telomerase. Furthermore, horseradish peroxidase (HRP)/indole-3-acetic acid (IAA) gene directed enzyme prodrug therapy (GDEPT) system was used to determine whether the combination of ONCOLOGY REPORTS 19: 281-286, 2008 281 Radio-activation of hTERT promoter in larynx squamous carcinoma cells: An 'indirected-activator' strategy in radio-gene-therapy irradiation and the hTERT promoter-controlled gene therapy was applicable to cancer gene therapy.
Materials and methods
Cell culture. The human HEp-2 larynx squamous carcinoma cell line (ATCC CCL-23) was obtained from the China Center for Type Culture Collection. Cells were cultured in RPMI-1640 medium supplemented with 10% calf serum (Gibco) and maintained at 37˚C with 5% CO 2 in a humidified incubator.
Plasmid DNA and cell transfection. The core hTERT promoter (-385/+40 bp) was kindly provided by Dr I. Horikawa (NIH/NCI) (10). For phTERTp-Luc, the promoter was placed upstream of the luciferase gene in the pGL3-Basic vector (Promega). For phTERTp-MCS, which was used as a negative control since there was no gene expression controlled by the hTERT promoter, the promoter from pcDNA3.1(-) (Invitrogen) was replaced with the hTERT promoter. The plasmid pRK5-HRP was a kind gift from Dr D.F. Cutler (UCL) (11) . The HRP cDNA was excised from pRK5-HRP by BamHI digestion (enzymes from Takara) and the resulting fragment was inserted into the multiple cloning site (MCS) directly downstream of the hTERT promoter in the plasmid phTERTp-MCS. Transient cell transfectants for all plasmid constructs were produced by using Metafectene™ (Biontex) according to the manufacturer's guidebook.
Reporter gene assay. Plates (6-well) were seeded with 4x10 5 cells/well. At an optical confluency of 90-100%, cells were cotransfected with 0.5 μg of plasmid phTERTp-Luc or pGL3-Basic (negative control plasmid, Promega) and 0.5 μg of pRL-TK (cotransfected standard plasmid, Promega). Cells were irradiated after transfection for 24 h and lysed for luciferase activity analyses at different time points postradiation, using the Dual-luciferase reporter assay system (Promega) as indicated by the manufacturer. Internal normalization of the transfection efficacy was performed using the value of Renilla luciferase (RL). The value of luciferase activity in negative control cells (cotransfected pGL3-Basic and pRL-TK) reflected the background, which were deducted.
Analysis of telomerase activity. Telomerase activity was determined using the TRAP PCR ELISA kit (Roche) as recommended by the manufacturer. Briefly, cell extracts were obtained from 2x10 5 cells lysed with 200 μl lysis buffer, incubated on ice for 30 min, and centrifuged at 16,000 g at 4˚C for 20 min. Protein concentration was determined by the commercial BCA protein assay kit (Beyotime). Each Trap reaction contained 50 μg total protein. The primer was elongated at 25˚C for 30 min, and then incubated at 94˚C for 5 min to induce the telomerase inactivation. The reaction mixture was then amplified by 30 cycles of polymerase chain reactions (PCR) at 94˚C for 30 sec, 50˚C for 30 sec, 72˚C for 90 sec, and 72˚C for 10 min for the final step. The amplification product (5 μl) was transferred for hybridization and ELISA procedure. Sample absorbance was measured with Model 550 microplate reader (Bio-Rad, USA) at the wavelength of 450/690 nm within 30 min after addition of the stop reagent. Each assay contained a negative and positive control included in the kit. All experiments were performed twice (triplicate samples) to ensure the reliability of the test.
Reverse transcriptase-PCR analysis. Total RNA was isolated from cells using TRI Reagent (MRC). First-strand cDNA was synthesized from 2 μg of RNA in 20 μl of reaction solution using the Revert aid first-strand cDNA synthesis kit (Fermentas). The hTERT cDNA, was amplified in a PCR reaction using the primers 5'-CTGCCGTCTTCACTTCCC CAC-3' (forward) and 5'-TTACTCCCACAGCACCTCCCC-3' (reverse) designed accordly to complete hTERT mRNA (NM_198253). The HRP cDNA (J05552) was amplified using the primers 5'-CCTTGTGGCTCTGTCCGGAGGA-3' (forward) and 5'-AGTGGGATGGTGTCAGTGGCGT-3' (reverse). As a control, we amplified the GAPDH cDNA (NM_002046) with the following primers: 5'-ACCACAGTC CATGCCATCAC-3' (forward) and 5'-TCCACCACCCTGT TGCTGTA-3' (reverse). The thermal cycling condition for hTERT PCR was: 94˚C for 5 min, followed by 35 cycles of 94˚C for 30 sec, 64˚C for 40 sec, and 72˚C for 1 min. For HRP PCR: 95˚C for 3 min, followed by 30 cycles of 94˚C for 1 min, 65˚C for 1 min, and 72˚C for 1 min. The PCR products were resolved on a 2.5% agarose gel and stained with ethidium bromide (Sigma). The average band densities of the PCR products were measured using Genetools software (Syngene). All experiments were repeated three times.
Western blotting. Western blot analysis for HRP expression was performed as described previously (16) . Briefly, HEp-2 cells that had been transfected with plasmid phTERTp-HRP or phTERTp-MCS (negative control) were washed with PBS and lysed in a protein extraction buffer according to the manufacturer's protocols (Beyotime). Cell lysates were collected, separated by 12% SDS-PAGE gels and transferred to nitrocellulose membranes (GE). The blocked membranes were then incubated with a primary antibody against HRP (Bioss) and then with the corresponding peroxidase were labeled as a secondary antibody (Pierce). Immunoreactive proteins were visualized using the DAB staining kit (Zsbio) according to the instructions provided. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a protein loading control.
Clonogenic assays. The effect of AZT on radiosensitivity of HEp-2 cells and the cytotoxicity of phTERTp-HRP/IAA GDEPT after activation by a radiation trigger were examined by clonogenic survival assays. After different treatments, indicated in the figure legends, the cells were cultured for 14 days. After fixation and staining with 1% crystal violet (Sigma) w/v in dehydrated alcohol, colonies of >50 cells were scored. The plating efficiency and survival fraction were calculated. The survival curves were obtained and analyzed with SPSS 11.0 statistical software to get the surviving fractions at 2 Gy-radiation (SF 2 ) of each group. Sensitizer enhancement ratio (SER) was defined as the ratio of the radiation dose required to obtain a specific surviving fraction (SF).
Statistical analyses. The data were expressed as mean ± standard deviation. Significance tests were carried out on the date groups by independent-samples t-test. Differences among the treatment groups were analyzed by the one-way ANOVA test. Differences between the survival fractions of the treatment groups were analyzed by the Chi-squared test. Correlations were assessed by bivariate correlation analysis. The data were analyzed using SPSS11.0 software (SPSS Inc., USA). P<0.05 was considered statistically significant.
Results
Decrease of telomerase activity and increase of radiosensitivity by AZT. We favor the hypothesis that telomerase may participate in the process of DNA repair and the up-regulation of telomerase may be a reaction to DNA damage induced by irradiation. In previous work, we observed that AZT (an hTERT inhibitor) could diminish the repair of the DNA strand breaks after irradiation and radiosensitize U251 cells (9) . Here, we found that AZT decreased the telomerase activity in HEp-2 cells and lowered the survival fraction of HEp-2 cells exposed to radiation (Fig. 1) . After 0.8 mM AZT incubation for 24 h, a significant down-regulation in telomerase activity was observed in HEp-2 cells (0.627±0.015 vs. 0.368±0.003, P<0.01, Fig. 1A ), which indicates that AZT suppressed the telomerase activity of the HEp-2 cells. Data showed that radiation alone caused a dose-dependent reduction and that HEp-2 cells were more radiosensitive after AZT treatment in cell survival (Fig. 1B) . SF 2 of HEp-2 cells dropped from 0.4147 (HEp-2 group) to 0.3843 (HEp-2+AZT group), SER 2Gy =1.079 (χ 2 =63.957, P<0.01).
Regulation of exogenous hTERT promoter activity and endogenous telomerase activity by irradiation.
In an effort to understand whether the exogenous hTERT promoter activity would be modulated by radiation and potential usage in controlling exogenous gene, the firefly luciferase was used as the reporter gene to determine the instantaneous activation of hTERT promoter after γ-ray exposure. Renilla luciferase (RL) was used for internal normalization and pGL3-Basic was used as a negative control and background value. The effects of single-dose radiation on endogenous telomerase activity were also studied to determine whether the level of telomerase activity would be modulated by radiation. hTERT promoter activity and telomerase activity varied at different dose levels and different time points post-irradiation in the HEp-2 cells transfected with plasmid phTERTp-Luc (Fig. 2) . A range of radiation doses, from 0 to 8 Gy, was chosen according to the hTERT promoter activity and telomerase activity was measured 24 h after irradiation. As shown in Fig. 2A , there was an increased hTERT promoter activity after cells were treated with relatively low doses of radiation (2-6 Gy), which resulted in 1.31-fold to 1.89-fold increased telomerase activity compared to the untreated controls (0 Gy group). The peak of the hTERT promoter activity (2.96±0.45-fold increase) was found in cells treated with 6 Gy-radiation, which resulted in telomerase activity of 1.89-fold increase ( Fig. 2A) . In order to prove the induction of hTERT promoter by radiation, 6 Gy-radiation was adopted for the following experiments. The hTERT promoter activity started to increase at 3 h post-irradiation and reached a peak (2.22±0.50-fold increase) at ~11 h after irradiation, which resulted in the maximal increasing telomerase activity (1.36±0.23-fold increase) (Fig. 2B) . Induced activity of hTERT promoter was shown in a dose-and time-dependent manner as that of telomerase activity (r=0.958, P<0.05, Fig.  2A ; r=0.950, P<0.05, Fig. 2B ), which indicated that exogenous hTERT promoter activity reflected the difference in endogenous telomerase activity.
Irradiation enhances both the exogenous and endogenous
hTERT promoter activity. In order to study the application of the hTERT promoter in gene therapy, the HRP/IAA system was adopted for use in the hTERT promoter-mediated gene therapy combined with radiation. Enhancement of hTERT mRNA expression, which was controlled by the endogenous hTERT promoter, was performed after 6 Gy-radiation treatment (Fig. 3) . The effective induction of the HRP mRNA expression, which was controlled by the exogenous hTERT promoter, was compared by RT-PCR in HEp-2 cells with complete absence in cells of the control group transfected with phTERTp-MCS (Fig. 3) . Syntheses of HRP protein were confirmed by Western blotting (Fig. 4) . According to the levels of HRP mRNA, 6 Gy-radiation had parallel effects on HRP protein expression, which showed a 1.9-fold increase within 24 h of irradiation. Detectable proteins were investigated in the control group (lane 3, Fig. 4) , which may be due to the mammalian homologues of HRP as the HRP mRNA were absent (control, Fig. 3) . HRP, isolated from the roots of a horseradish plant, is a heme enzyme and its active site resembles that of hemoglobin and myoglobin (13) . Based on published amino acid sequence, the construct encoding HRP isoenzyme C was artificially constructed and incorporated into the plasmid by Cutler et al (11) . Thus, there is no endogenous HRP in HEp-2 cells.
Radiation increases the cytotoxicity of phTERTp-HRP/IAA
GDEPT. At the doses of 0.25 to 2 mM, cytotoxic effects of IAA (Fluka) were previously measured. No toxicity was detected in mock-transfected HEp-2 cells exposed for 48 h to up to 0.5 mM IAA (data not shown), therefore 0.5 mM was chosen. Prodrug IAA incubation was performed after trigger treatment, and the efficacy of the hTERT promoter induction was compared with a single component control after the . Twenty-four hours later, cells were exposed to a culture medium containing 0.5 mM IAA resolved in phenol red-free Hanks balanced salt solution (HBSS) for 24 h. Then, cells were treated with a single-dose radiation (0, 1, 2, 3 Gy); ii) HRP+Trigger+IR: cells were treated like group 1 except for a mock IAA incubation, in which cells were exposed to a culture medium supplemented with 10% foetal calf and HBSS without IAA; iii) HRP+IAA+IR: cells were treated like group 1 except for a mock-trigger; iv) HRP+IR: cells were exposed to mock-trigger and mock IAA incubation before the single-dose radiation. Surviving fraction was normalized for the plating efficiency of cells in the control group irradiated with 0 Gy-radiation. The means of two experiments (triplicate samples) ± SD are shown. The surviving fractions were compared to the HRP+Trigger+AA+IR group exposed to the same single-dose radiation. Statistically significant differences ( ** P<0.01).
HEp-2 cells were exposed to a single-dose radiation (0, 1, 2, 3 Gy) (Fig. 5) . To evaluate the application of this strategy, plasmids phTERTp-HRP were transiently transfected into HEp-2 cells. In the 0 Gy group, as expected, when the hTERT promoter alone was used to control HRP expression, HEp-2 cells were not killed after 0.5 mM IAA incubation for 24 h (p>0.05), probably due to the low activity of the hTERT promoter. In addition, 21.1% of the HEp-2 cells survived after 6 Gy-radiation exposure. Conversely, when HRP expression controlled by the hTERT promoter combined with trigger (6 Gy-radiation), only 0.95% of HEp-2 cells survived after IAA incubation, which accorded with the up-regulated expression of HRP (Figs. 3 and 4) and indicated that stimulation of irradiation dramatically induced the activity of hTERT promoter. We investigated whether conventional treatments augment the efficacy of the combination of trigger and phTERTp-HRP/IAA GDEPT. The cells were exposed to a low-dose radiation (1-3 Gy) after treatments. As shown in Fig. 5 , combination strategy dramatically increased the cytotoxicity induced by HRP/IAA GDEPT in each group. On the other hand, higher radiation doses show more significant combination effects with phTERTp-HRP/IAA. These results suggest that the cytotoxicity of phTERTp-HRP/ IAA is preferably combined with irradiation. Nonspecific activation of IAA in normal tissues is unlikely to take place, since IAA is a poor substrate for mammalian peroxidases (14) . Endogenous myeloperoxidase (MPO) was notably less efficient than HRP in converting IAA into a cytotoxin at therapeutically significant prodrug doses (15) . Thus, cytotoxin must come from exogenous HRP/IAA.
Discussion
We found that the activities of the exogenous hTERT promoter and endogenous telomerase in HEp-2 cells can be induced by irradiation. The up-regulated activity of both exogenous and endogenous hTERT promoters may be a reaction to DNA damage, which is one of the mechanisms involved in increased telomerase activity after irradiation. These observations indicate that the 'indirected-activator' strategy may be able to amplify the targeted killing effect of hTERT promoter mediated gene therapy due to the DNA damage response after irradiation. Gene therapy approaches based on the selective expression of therapeutic genes present a number of distinct advantages. The targetability of radiation therapy offers a unique opportunity to control therapeutic gene expression (16) . Some researchers have used promoters of radiation-inducible genes to drive the transcription of transgenes in the response to radiation. For example, the early growth response-1 (Egr-1) gene promoter, the first radiation inducible promoter system, was inducible by exposure to ionizing radiation via radical oxygen intermediate (ROI) formation and that the CArG (CC [AtT-rich] 6GG) domain of the promoter are the sequences necessary (17) . In this study, we proved there is an 'indirected-activator' strategy which can be used in targeted gene therapy. The strategy uses radiation-induced DNA damage as a therapeutic tool and as an activator to enhance the activity of the hTERT promoter. This hypothesis may explain the satisfactory results obtained in few studies, which had combined radiotherapy with gene therapy using the hTERT promoter (18, 19) .
There is increasing evidence that proteins involved in DNA damage response, including Ku, DNA-PKcs, RAD51D, PARP-2, WRN and RAD50/MRE11/NBS1 complex directly participate in telomere maintenance. A close association between telomeres and different DNA damage response factors is a logical result of chromosomal integrity maintenance activities (20) . Although the exact mechanism of DNA repair is not clear, many scholars believe that the activation of telomerase observed post-radiation may be due to the involvement of telomerase in DNA repair and chromosome healing (21, 22) . In previous work, we observed that a reverse transcriptase inhibitor (AZT) suppressed the induction of the telomerase activity by γ-irradiation, decelerated the restored rate of shortened telomere, decreased the repair rate of the DNA strand breaks, and increased the radiosensitivity in U251 cells (9) . In this assay, we know that telomerase also plays an integral role in DNA repair, since after AZT treatment, HEp-2 cells displayed an obvious decrease in telomerase activity and in DNA repair capacity shown as an increase of radiosensitivity. In addition, hTERT promoter activity, hTERT mRNA expression, and telomerase activity were up-regulated by irradiation, which suggests DNA damage response factors may increase telomerase activity by increasing hTERT expression at the promoter level and may be one of the mechanisms involved in radiosensitivity in tumor cell lines.
Although induced activity of the hTERT promoter was shown in both a time-and dose-dependent manner as that of telomerase activity, the increasing levels were not consistent in our study. The regulation mechanism of hTERT activation has not been confirmed yet. Few previous works have shown that hTERT activation subjects to transcriptional or posttranslational regulation, and that the telomerase activities and the hTERT mRNA levels in cancer cells were not always in parallel (23, 24) . However, in this study, the radiation-induced response has been demonstrated at the expression level for exogenous hTERT promoter activity, endogenous telomerase activity, and hTERT mRNA controlled by endogenous hTERT promoter. We hypothesize that transcriptional regulation is essential to telomerase activity in cells with DNA damage after irradiation. Few cell lines have exhibited different regularities according to the time and doses used. For example, HeLa cells and ataxia-telangiectasia cells show a dose-dependent (0 to 40 Gy) decrease in telomerase activity after ionizing radiation (25) . The activity of the hTERT promoter and expression of hTERT mRNA may be more essential than telomerase activity in reflecting radiosensitivity. Since there may be some post-translational regulations that have negative effects on telomerase activity, additional studies in activity regulation of telemerase due to radiation are certainly required.
The usefulness of the hTERT promoter has been proven in targeted gene therapy, but the weak activity hinders its therapeutic applications. Radiotherapy is one of the main methods in cancer therapy. In the 'indirected-activator' strategy, precise radiotherapy was utilized to target enhanced therapeutic gene expression controlled by the hTERT promoter, which may achieve both high-selectivity and high-efficiency in cancer-targeted gene therapy. With a view to combining targeted gene therapy with conventional radiotherapy, an increase in therapeutic gain could be achieved both at the level of the promoter and the therapeutic gene (26) . For example, the HRP/IAA system, a novel GDEPT system, exhibited a rapid efficiency in killing tumor cells with a strong bystander effect both in anoxic and oxic conditions and showed a significant synergistic effect with radiation (12, 27) . Thus, this system is promising if it is to be used in combination with radiotherapy and gene therapy.
To determine whether the 'indirected-activator' strategy was applicable to cancer gene therapy, plasmid vectors were tested, in which the tumor-targeted and radiation-inducible hTERT promoter controlled the production of the enzyme HRP. HEp-2 cells were transiently transfected with these constructs and their sensitivity to prodrug IAA was examined. As predicted, HRP expressed only in cells transfected with phTERTp-HRP and the expression level after 6 Gy-radiation is much higher than without irradiation. In cells with elevated HRP level, 6 Gy-radiation trigger has shown to render the transfected HEp-2 cells to be more sensitive to IAA-induced killing, which indicated that radio-activation of the promoter did occur and is able to contribute to gene therapy efficacy.
The results presented here demonstrate that combining radiotherapy with the hTERT promoter-mediated gene therapy is therefore a promising approach to achieve superior efficacy in targeted cell killing.
The hTERT promoter has been widely used in gene therapy for targeted cancer cells. Combined with radiotherapy, these cancer-targeted gene therapy approaches may achieve a more satisfactory curative effect. The results presented here demonstrate, for the first time, irradiation can be used to enhance the activity of the hTERT promoter. Our data provide support for the hypothesis that the tumor-targeted hTERT promoter can be used to drive transcription of transgenes in the response to DNA-damaging agents, such as irradiation and some chemotherapy drugs.
